Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE DES LILAS : revenue, balance sheet and financial ratios

SELARL PHARMACIE DES LILAS is a French company founded 7 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in HERBLAY-SUR-SEINE (95220), this company of category PME shows in 2024 a net income positive of 240 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DES LILAS (SIREN 849538582)
Indicator 2024 2023 2022 2021 2020
Revenue N/C N/C N/C N/C N/C
Net income 240 071 € 247 323 € 317 756 € 319 951 € 105 888 €
EBITDA N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SELARL PHARMACIE DES LILAS generates positive net income of 240 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2024: 106 k€ -> 240 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

240 071 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 110%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 39%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

109.98%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

38.792%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

28.9%

Solvency indicators evolution
SELARL PHARMACIE DES LILAS

Sector positioning

Debt ratio
109.98 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average -10 pts over 3 years

In 2024, the debt ratio of SELARL PHARMACIE DES LILAS (109.98) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
38.79% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average +7 pts over 3 years

In 2024, the financial autonomy of SELARL PHARMACIE DES LILAS (38.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 223.73. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

223.728

Liquidity indicators evolution
SELARL PHARMACIE DES LILAS

Sector positioning

Liquidity ratio
223.73 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good -12 pts over 3 years

In 2024, the liquidity ratio of SELARL PHARMACIE DES LILAS (223.73) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of SELARL PHARMACIE DES LILAS in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE DES LILAS is estimated at 3 351 568 € (range 2 333 979€ - 5 014 138€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
2333k€ 3351k€ 5014k€
3 351 568 € Range: 2 333 979€ - 5 014 138€
NAF 5 année 2024

Valuation method used

Net Income Multiple
240 071 € × 14.0x = 3 351 569 €
Range: 2 333 979€ - 5 014 138€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DES LILAS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DES LILAS

What is the revenue of SELARL PHARMACIE DES LILAS ?

The revenue of SELARL PHARMACIE DES LILAS is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE DES LILAS profitable?

Yes, SELARL PHARMACIE DES LILAS generated a net profit of 240 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE DES LILAS ?

The headquarters of SELARL PHARMACIE DES LILAS is located in HERBLAY-SUR-SEINE (95220), in the department Val-d'Oise.

Where to find the tax return of SELARL PHARMACIE DES LILAS ?

The tax return of SELARL PHARMACIE DES LILAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DES LILAS operate?

SELARL PHARMACIE DES LILAS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.